Orchestra BioMed Hldgs Q2 EPS $(0.45) Misses $(0.39) Estimate, Sales $778.00K Beat $750.00K Estimate
Author: Benzinga Newsdesk | August 12, 2024 04:38pm
Orchestra BioMed Hldgs (NASDAQ:
OBIO) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 28.57 percent decrease over losses of $(0.35) per share from the same period last year. The company reported quarterly sales of $778.00 thousand which beat the analyst consensus estimate of $750.00 thousand by 3.73 percent. This is a 14.97 percent decrease over sales of $915.00 thousand the same period last year.
Posted In: OBIO